Topics
Glioblastoma | Treatment | Immunotherapy | Viruses
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Viruses
*Rossmeisl JH, King JN, Robertson JL, Weger-Lucarelli J,
Elankumaran S.
Phase I/II Trial of
Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle
Disease Virus for Canine Intracranial Tumors.
Cancers
(Basel). 2024 Jan 29;16(3):564. doi:
10.3390/cancers16030564. PMID:
38339315. Interventional animal study. ˍ
Calderón-Peláez MA, Maradei Anaya SJ,
Bedoya-Rodríguez IJ, González-Ipuz KG, Vera-Palacios
D, Buitrago IV, Castellanos JE, Velandia-Romero ML.
Zika
Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling
Its Potential for Oncolytic Virotherapy.
Viruses.
2024 Apr 3;16(4):561. doi:
10.3390/v16040561. PMID:
38675903;. Review. ˍ
Keshavarz
M, Dianat-Moghadam H, Ghorbanhosseini SS, Sarshari B.
Oncolytic
virotherapy improves immunotherapies targeting cancer stemness in
glioblastoma.
Biochim
Biophys Acta Gen Subj.
2024 Jun 18;1868(9):130662. doi:
10.1016/j.bbagen.2024.130662. PMID:
38901497. Review˰
ˍ
Stergiopoulos GM, Concilio SC, Galanis E.
An
Update on the Clinical Status, Challenges, and Future Directions
of Oncolytic Virotherapy for Malignant Gliomas.
Curr
Treat Options Oncol. 2024 Jun 19. doi:
10.1007/s11864-024-01211-6. PMID:
38896326. Review˰
ˍ
Kim S, Jung BK, Kim J, Jeon JH, Kim M, Jang SH, Kim CS, Jang H.
Anticancer effect of the oncolytic
Newcastle disease virus harboring the PTEN gene on glioblastoma.
Oncol
Lett. 2024 Oct 16;29(1):6. doi:
10.3892/ol.2024.14752. PMID:
39492938. Laboratory investigation. ˍ
Gunasegaran B, Ashley CL,
Marsh-Wakefield F, Guillemin GJ, Heng B.
Viruses
in glioblastoma:
an update on evidence and clinical trials.
BJC
Rep. 2024 Apr
19;2(1):33. doi:
10.1038/s44276-024-00051-z.
PMID:
39516641. Review. ˍ
Meléndez-Vázquez NM, Gomez-Manzano C, Godoy-Vitorino
F.
Oncolytic Virotherapies and
Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against
Malignant Gliomas.
Viruses.
2024 Nov 14;16(11):1775. doi:
10.3390/v16111775. PMID:
39599889. Review. ˍ
Coates K, Nibbs RJ, Fraser AR.
Going
viral: targeting glioblastoma using oncolytic viruses.
Immunother
Adv. 2025 Jul 25;5(1):ltaf024. doi:
10.1093/immadv/ltaf024. PMID:
40717958.
Review.
ˍ
Alomari O, Eyvazova H, Güney B, Al Juhmani R, Odabasi H,
Al-Rawabdeh L, Mokresh ME, Erginoglu U, Keles A, Baskaya
MK.
Oncolytic
Therapies for Glioblastoma:
Advances, Challenges, and Future Perspectives.
Cancers
(Basel). 2025 Aug 1;17(15):2550. doi:
10.3390/cancers17152550. PMID:
40805247.
Review.
ˍ
Daftari M, Ramsoomair CK, Aaronson D, Seetharam D, Andreae EA,
Wright L, Han S, Chandar J, Lu V, Govindarajan V, Ivan ME, Komotar
RJ, de la Fuente M, Shah AH.
Synergistic
Treatment with Antiretrovirals and Laser Interstitial Thermal
ThErapy (STARLITE) for unresectable glioblastoma: A phase 1 study
protocol.
PLoS
One. 2025 Aug 28;20(8):e0328204. doi:
10.1371/journal.pone.0328204. PMID:
40875628. Interventional study protocol. ˍ
Zhang X, Li Y, Liu N, Zhang Y, Yang N, Zhou L.
Oncolytic
virus therapy for glioma: current clinical trials and overcoming
key obstacles.
Int
Immunopharmacol. 2025 Sep 15;166:115547. doi:
10.1016/j.intimp.2025.115547. PMID:
40957170. Review˰
ˍ